$2.30 Billion in Sales Expected for Lam Research Co. (LRCX) This Quarter
Equities analysts expect Lam Research Co. (NASDAQ:LRCX) to announce sales of $2.30 billion for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Lam Research’s earnings, with the lowest sales estimate coming in at $2.30 billion and the highest estimate coming in at $2.31 billion. Lam Research reported sales of $2.48 billion in the same quarter last year, which indicates a negative year-over-year growth rate of 7.3%. The business is scheduled to announce its next earnings report on Tuesday, October 16th.
According to Zacks, analysts expect that Lam Research will report full-year sales of $10.53 billion for the current year, with estimates ranging from $9.93 billion to $11.38 billion. For the next year, analysts expect that the business will report sales of $11.78 billion per share, with estimates ranging from $10.85 billion to $12.06 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Lam Research.
Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Thursday, July 26th. The semiconductor company reported $5.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $0.37. Lam Research had a net margin of 21.49% and a return on equity of 47.14%. The business had revenue of $3.13 billion during the quarter, compared to the consensus estimate of $3.08 billion. During the same quarter last year, the firm posted $3.11 EPS. Lam Research’s revenue was up 33.3% compared to the same quarter last year.
A number of hedge funds have recently bought and sold shares of the business. Boston Partners purchased a new position in shares of Lam Research during the first quarter worth about $636,000. Financial Gravity Wealth Inc. purchased a new position in shares of Lam Research during the first quarter worth about $165,000. Neuberger Berman Group LLC grew its holdings in shares of Lam Research by 21.1% during the first quarter. Neuberger Berman Group LLC now owns 188,427 shares of the semiconductor company’s stock worth $38,319,000 after purchasing an additional 32,886 shares in the last quarter. Systematic Financial Management LP grew its holdings in shares of Lam Research by 57.6% during the first quarter. Systematic Financial Management LP now owns 63,859 shares of the semiconductor company’s stock worth $12,974,000 after purchasing an additional 23,340 shares in the last quarter. Finally, Rockefeller Capital Management L.P. purchased a new position in shares of Lam Research during the first quarter worth about $335,000. 89.15% of the stock is owned by institutional investors and hedge funds.
NASDAQ LRCX traded down $0.12 during mid-day trading on Tuesday, hitting $155.16. The company’s stock had a trading volume of 34,353 shares, compared to its average volume of 2,701,426. Lam Research has a twelve month low of $149.02 and a twelve month high of $234.88. The company has a current ratio of 2.90, a quick ratio of 2.31 and a debt-to-equity ratio of 0.27. The company has a market cap of $24.14 billion, a P/E ratio of 8.69, a PEG ratio of 0.59 and a beta of 1.33.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 26th. Shareholders of record on Wednesday, September 12th will be issued a dividend of $1.10 per share. This represents a $4.40 dividend on an annualized basis and a yield of 2.84%. The ex-dividend date of this dividend is Tuesday, September 11th. Lam Research’s payout ratio is presently 24.62%.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition product for copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatment; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition (ALD) products; and VECTOR plasma-enhanced CVD ALD products.
Featured Article: Marijuana Stocks Investing Considerations
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.